CTI is a recently introduced index designed to assess inflammation (via CRP) and insulin resistance (via TyG), both of which are risk factors for DM and osteopenia/OP, and it is a direct, rapid indicator at no additional cost beyond standard laboratory tests. This evidence concerns the gene CRP and Insulin resistance.